We have also shown that plakoglobin expression in the mutant p53 (R280K)- expressing and highly invasive breast carcinoma cells MDA-MB-231 increased nuclear NPM level and this redistribution was concurrent with the decreased in vitro tumorigenic properties of these cells [[58] Figs 4 and 5 therein]. The gene discussed is TP53; the disease is breast carcinoma.